Search Results - Priscila Scheinberg
- Showing 1 - 6 results of 6
-
1
-
2
-
3
-
4
-
5
Moderate-dose cyclophosphamide for severe aplastic anemia has significant toxicity and does not prevent relapse and clonal evolution by Phillip Scheinberg, Danielle Townsley, Bogdan Dumitriu, Priscila Scheinberg, Barbara Weinstein, Maithili M. Daphtary, Olga Rios, Colin O. Wu, Neal S. Young
Published 2014Artigo -
6
Alemtuzumab in T-cell large granular lymphocytic leukaemia: interim results from a single-arm, open-label, phase 2 study by Bogdan Dumitriu, Sawa Ito, Xingmin Feng, Melanie R. Nicol, Yunce Muharrem, Sachiko Kajigaya, Joseph Melenhorst, Olga Rios, Priscila Scheinberg, Fariba Chinian, Keyvan Keyvanfar, Minoo Battiwalla, Colin O. Wu, Irina Marić, Liqiang Xi, Mark Raffeld, Pawel Muranski, Danielle M. Townsley, Neal S. Young, Austin John Barrett, Phillip Scheinberg
Published 2015Artigo
Search Tools:
Related Subjects
Gastroenterology
Internal medicine
Medicine
Aplastic anemia
Bone marrow
Anemia
Surgery
Biology
Chemotherapy
Cyclophosphamide
Globulin
Immunology
Transplantation
Alemtuzumab
Astrobiology
Confidence interval
Horse
Neutropenia
Paleontology
Refractory (planetary science)
Toxicity
Absolute neutrophil count
CD52
CD8
Clinical endpoint
Clinical trial
Hematopoietic stem cell transplantation
Immune system
Interim analysis
Leukopenia